Shen, Ning
Lu, Shangwei
Kong, Zhijuan
Gao, Ying
Hu, Jinxiu
Si, Shuxuan
Wang, Junlin
Li, Jie
Han, Wei
Wang, Rong
Lv, Zhimei
Funding for this research was provided by:
Shandong Province Natural Science Foundation Joint Fund (No. ZR2022LSW020)
National Natural Science Foundation of China (82370721, 81873615)
Taishan Scholars Program (ts201712090, tsqn201812138)
Article History
Received: 9 April 2024
Accepted: 21 June 2024
First Online: 16 July 2024
Declarations
:
: About research on immune cells, all participants signed informed consent to study protocols approved by the Sardinian Regional Ethics Committee (protocol no. 2171/CE). All studies were approved by local ethics committees, and all participants provided written, informed consent. Informed consent was obtained from all participants and/or their LAR. The study of metabolite was approved by the research ethics boards of the Jewish General Hospital, protocol number 2021-2762.
: All authors have read the manuscript and approved its submission to the Diabetology and Metabolic Syndrome.
: The authors declare no competing interests.